Photo: Emovi MONTREAL, March 4, 2019 /CNW Telbec/ - Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its …
Please use our dedicated page for Funding Requests!
We have added a new page to the website to ensure timely processing of your funding requests. Please use this dedicated page to file your deals with us: …
2019 TVM Capital Winter Conference
Celebrate with us our 11th biennial Winter Conference in February 2019 where we will discuss the 'New Champions in Life Science'. The purpose of this biennial event is to provide a high profile …
1. Tiroler Biotech Konferenz an der UMIT: „Where Life Science Meets Capital“
Einzigartige Initiative von privatem Risikokapital und öffentlicher Hand unter Beteiligung des Landes Tirol und seinen Universitäten , der Hypo Tirol Bank sowie dem Innovationsspezialisten …
CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials
CENTOGENE and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic collaboration for the global identification and recruitment of LRRK2 mutation carrier Parkinson’s disease (“PD”) …
F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma
Acquisition reflects progress in development of technology to deliver biologic therapeutics across the blood-brain barrier Upfront payments of $24M with contingent additional milestones up to …
Lilly to Acquire AurKa Pharma
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types INDIANAPOLIS, IN – Eli Lilly and Company (NYSE:LLY) today announced an agreement to acquire …
Rapid Micro Biosystems Secures $60 Million In Equity Financing
Investment to Accelerate Company's Continued Global Commercial Expansion and Product Innovation Lowell, MA – May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, …
Deinove To Acquire Biovertis/Morphochem
Deinove Gains Access to Biovertis/Morphochem’s Lead Compound MCB3837 for the Potential Treatment of Clostridium Difficile Infections (CDI) Vienna/Munich, 13 April 2018: Biovertis AG, Vienna and TVM …
Prof. Arndt Rolfs joins newly formed “Global Commission to End the Diagnostic Odyssey”
Prof. Arndt Rolfs, CENTOGENE AG, has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a dedicated group of technology innovators, patient advocates, healthcare …